Differenzialdiagnose und Therapie des Nystagmus mit pathologischer Schlagform

H.-C. Leopold

doi:10.1055/s-0032-1312843

Fortschritte der Neurologie · Psychiatrie, Table of Contents

Fortschr Neurol Psychiatr 2012; 80(7): 407-417
DOI: 10.1055/s-0032-1312843

Fort- und Weiterbildung

Differenzialdiagnose und Therapie des Nystagmus mit pathologischer Schlagform

Differential Diagnosis and Therapy of Pendular Nystagmus and Saccadic Oscillations

H.-C. Leopold

Abstract

Full Text

References

Literatur
1 Brandt T, Büchele W. Augenbewegungsstörungen. Stuttgart: Gustav Fischer; 1983
2 Huber A, Kömpf D. Klinische Neuroophthalmologie. Stuttgart: Thieme; 1998
3 Leigh RJ, Zee DS. The neurology of eye movements. New York: Oxford University Press; 2006
4 Thömke F. Augenbewegungstörungen. Stuttgart: Thieme; 2008
5 Leopold HC. Opsoklonus- und Myoklonie-Syndrom. Fortschr Neurol Psychiat 1985; 53: 42-54
6 Gresty MA, Ell JJ, Findley LJ. Acquired pendular nystagmus: ist characteristics, localizing value and pathophysiology. J Neurol Neurosurgery Psychiatry 1982; 45: 431-439
7 Lopez LI, Bronstein AM, Gresty MA et al. Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. Brain 1996; 119: 465-472
8 Das VE, Oruganti P, Kramer PD et al. Experimental tests of a neural-network model for ocular oscillations caused by disease of central myelin. Exp Brain Res 2000; 133: 189-197
9 Samuel M, Torun N, Tuite PJ et al. Progressive ataxia and palatal tremor (PAPT): clinical and MRI assessment with review of palatal tremors. Brain 2004; 127: 1252-1268
10 Tilikete C, Jasse L, Pelisson D et al. Acquired pendular nystagmus in multiple sclerosis and oculopalatal tremor. Neurology 2011; 76: 1652-1657
11 Lopez JL, Zee DS, Levi L. Eye closure and oculopalatal tremor. Neurology 2011; 77: 1929
12 Guillain G, Mollaret P. Deux cas de myoclonies synchrones et rhythmeés vélo-pharyngo- laryngo-oculo-diaphragmatiques: Le problème anatomique et physiopathologique de ce syndrome. Rev Neurol 1931; 2: 545-566
13 Shaikh AG, Hong S, Liao K et al. Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity. Brain 2010; 133 (03) 923-940
14 Schwartz MA, Selhorst JB, Alfred S et al. Oculomasticatory myorrhythmia: a unique movement disorder occurring in Whipple’s disease. Ann Neurol 1986; 20: 677-683
15 Hauser-Hauw C, Roullet E, Robert R et al. Oculo-Facio-Skeletal Myorhythmia as a Cerebral Complication of Systemic Whipple’s Disease. Mov Disord 1988; 3: 179-184
16 Averbuch-Heller L, Zivotofsky AZ, Remler BF et al. Convergent-Divergent Pendular Nystagmus: Possible Role of the Vergence System. Neurology 1995; 45: 509-515
17 Gamlin PDR, Mitchell KR. Reversible lesions of nucleus reticularis tegmenti pontis affect convergence and ocular accommodation (abstract). Soc Neurosci Abstr 1993; 19: 346
18 Yousry I, Dieterich M, Naidich TP et al. Superior oblique myokymia: magnetic resonance imaging support for the neurovascular compression hypothesis. Ann Neurol 2002; 51: 361-368
19 Kattah JC, Fitz Gibbon EJ. Superior oblique myokymia. Curr Neurol Neurosci Rep 2003; 3: 395-400
20 Morrow MJ, Sharpe JA, Ranalli PJ. Superior oblique myokymia associated with a posterior fossa tumor: Oculographic correlation with an idiopathic case. Neurology 1990; 40: 367-370
21 Norton EW, Cogan DG. Spasmus nutans: a clinical study of twenty cases followed two years or more sinc onset. Arch Ophthalmol 1954; 52: 442-446
22 Gresty MA, Leech J, Sanderds M et al. A study of head and eye movement in spasmus nutans. Br J Ophthalmology 1976; 60: 652-654
23 Gottob I, Reinecke RD. Spasmus nutans: Neue Erkenntnisse und Differentialdiagnose. Spektrum Augenheilk 1976; 10: 97-99
24 Antony JH, Ouvrier RA, Wise G. Spasmus nutans: a mistaken identity. Arch Neurol 1980; 37: 373-375
25 Unsöld R, Ostertag C. Nystagmus in suprasellar tumors: recent advances in diagnosis and therapy. Strabismus 2002; 1: 173-177
26 Kiblinger GD, Wallace BS, Hines M et al. Spasmus nutans-like nystagmus is often associated with underlying ocular, intracranial, or systemic abnormalities. J Neuroophthalmol 2007; 27: 118-22
27 Kommerell G. Kongenitaler Nystagmus, okulärer Nystagmus, erworbener Fixationsnystagmus und Spasmus nutans. In: Huber A, Kömpf D. Klinische Neuroophthalmologie. Stuttgart: Thieme; 1998: 571-575
28 Leigh RJ, Zee DS. Eye movements of the blind. Invest ophthalmol Vis Sci 1980; 19: 328-331
29 Rahman W, Proudlock F, Gottlob I. Oral Gabapentin Treatment for Symptomatic Heimann-Bielschowsky Phenomenon. Am J Ophthalmol 2006; 141: 221-222
30 Jeong SH, Oh YM, Hwang JM et al. Emergence of diplopia and oscillopsia due to Heimann-Bielschowsky phenomenon after cataract surgery. Br J Ophthalmol 2008; 92: 1402
31 Bronstein AM, Gresty MA, Mossman SS. Pendular pseudonystagmus arising as a combination of head tremor and vestibular failure. Neurology 1992; 42: 1527-1531
32 Shaikh AG, Reich S, Zee DS. Pseudonystagmus – clinical features and quantitative characteristics. Nat Rev Neurol 2010; 6: 519-523
33 Jacobs JB, Dell’Osso LF. Congenital nystagmus: Hypothesis for its genesis and complex waveforms within a behavioral ocular motor system model. J Vis 2004; 4: 604-625
34 Wong A. An update on opsoclonus. Curr Opin Neurol 2007; 20: 25-31
35 Van Erp WS, Bakker NA, Aries MJH. Opsoclonus and multiple cranial neuropathy as a manifestation of neuroborreliosis. Neurology 2001; 77: 1013-1014
36 Bataller L, Graus F, Saiz A et al. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 2001; 124: 437-443
37 Brunklaus A, Pohl K, Zuberi SM et al. Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life. Pediatrics 2011; 128 (02) e388-e394
38 Abadi RV, Gowen E. Characteristics of saccadic intrusions. Vision Res 2004; 44: 2675-2269
39 Herishanu YO, Sharpe JA. Saccadic intrusions in internuclear ophthalmoplegia. Ann Neurol 1983; 14: 67-72
40 Klotz L, Klockgether T. Multiple system atrophy with macrosquarewave-jerks. Mov Disord 2005; 20: 253-254
41 Cogan DG. Ocular dysmetria; flutterlike oscillations of the eyes and opsoclonus. AMA Arch Ophthalmol 1954; 51: 318-335
42 Ramat S, Leigh RJ, Zee DS et al. What clinical disorders tell us about the neural control of saccadic eye movements. Brain 2007; 130: 10-35
43 Shaik AG, Miura K, Optican LM. A new familial disease of saccadic oscillations and limb tremor provides clues to mechanisms of common tremor disorders. Brain 2007; 130: 3020-3031
44 Strupp M, Thurtell MJ, Shaikh AG et al. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol 2011; 258: 1207-1222
45 Leigh RJ, Tomsak R. Drug treatments for eye movement disorders. J Neurol Neurosurg Psychiatry 2003; 74: 1-4
46 Tychsen L, Sitaram N. Catecholamine depletion produces irreversible saccadic eye movements in normal humans. Ann Neurol 1989; 25: 444-449
47 Averbuch-Heller L, Tusa RJ, Fuhry L et al. A doubleblind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997; 41: 818-825
48 Starck M, Albrecht H, Pöllmann W et al. Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. J Neurol 2010; 257: 322-327
49 Thurtell MJ, Joshi AC, Leone AC et al. Crossover trial of gabapentin and memantine as treatment for acquired nystagmus. Ann Neurol 2010; 67: 676-680
50 Shery T, Proudlock FA, Sarvananthan N et al. The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study. Br J Ophthalmol 2006; 90: 839-843
51 Jain S, Proudlock F et al. Combined pharmakological and surgical approach to acquired nystagmus due to multiple sclerosis. Am J Opthalmol 2002; 134: 780-782
52 Starck M, Albrecht H, Straube A et al. Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurology 1997; 244: 9-16
53 Schon F, Hart PE, Hodgson P et al. Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. Neurology 1999; 23: 2209-2210
54 Traccis S, Rosati G, Monaco MF et al. Successful treatment of acquired pendular elliptical nystagmus in multiple sclerosis with isoniazid and baseout-prisms. Neurology 1990; 40: 492-494
55 Lefkowitz D, Harpold G. Treatment of ocular myoclonus with valproic acid. Ann Neurol 1985; 17: 103-104
56 Gledhill RF, Wiles CM. Clonazepam and branchial myoclonus. Ann Neurol 1977; 1: 306-307
57 Sakai T, Shiraishi S, Murakami S. Palatal myoclonus responding to carbamazepine. Ann Neurol 1981; 9: 199-200
58 Ferro JM, Castro-Caldas A. Palatal myoclonus and carbamazepine. Ann Neurol 1981; 10: 402
59 Jabbari B, Rosenberg M, Scherokman B et al. Effectivness of trihexyphenidyl against pendular nystagmus and pendular myoclonus: evidence of cholinergic dysfunction. Mov Disord 1987; 2: 93-98
60 Simpson DA, Wishnow R, Gargulinski RB et al. Oculofacial-Skeletal Myorhythmia in Central Nervous System Whipple’s Disease: Additional Case and Review of the Literature. Mov Disord 1995; 10: 195-200
61 McLean R, Proudlock F, Thomas S et al. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin. Ann Neurol 2007; 61: 130-138
62 Dell’Osso LF. Development of new treatments for congenital nystagmus. Ann N Y Acad Sci 2002; 956: 361-379
63 Frisén K, Wikkelsö C. Posttraumatic seesaw nystagmus abolished by ethanol ingestion. Neurology 1986; 36: 841-844
64 Lepore FE. Ethanol-induced reduction of pathological nystagmus. Neurology 1987; 37: 887
65 Cochin JP, Hannequin D, Domarcolino C et al. Intermittent see-saw nystagmus abolished by clonazepam. Rev Neurol 1995; 151: 60-62
66 Williams PE, Purvin VA, Kawasaki A. Superior oblique myokymia: Efficacy of medical treatment. J AAPOS 2007; 11: 254-257
67 Tomsak RL, Kosmorsky GS, Leigh RJ. Gabapentin attenuates superior oblique myokymia. Am J Ophthalmol 2002; 133: 721-723
68 Hüfner K, Linn J, Strupp M. Recurrent attacks of vertigo with monocular oscillopsia. Neurology 2008; 71: 863
69 Jain S, Farooq SJ, Gottlod I. Resolution of superior oblique myokymia with memantine. J AAPOS 2008; 12: 87-88
70 Pranzatelli MR, Tate ED, Swan JA et al. B Cell Depletion Therapy for New-Onset Opsoclonus-Myoclonus. Mov Disord 2010; 25: 238-242
71 Groiss SJ, Siebler M, Schnitzler A. Full Recovery of Adult Onset Opsoclonus Myoclonus Syndrome After Early Immunotherapy: A Case Report. Mov Disord 2011; 26: 1805-1807
72 Pranzatelli MR, Tate ED, Dukart WS et al. Sleep disturbance and rage attacks in opsoclonus-myoclonus syndrome: response to trazodone. J Pediatr 2005; 147: 372-378
73 Averbuch-Heller l, Leigh RJ. Medical treatments for abnormal eye movements. Austr N Z J Ophthalmol 1997; 25: 81-87
74 Serra A, Liao K, Martinez-Conde S et al. Suppression of saccadic intrusions in heriditary ataxia by memantine. Neurology 2008; 70: 810-812
75 Noorden GK von, Munoz M, Wong SY. Compensatory mechanisms in congenital nystagmus. Am J Ophthalmol 1987; 104: 387
76 Biousse V, Newman N. Neuro-Ophthalmology Illustrated. Stuttgart: Thieme; 2005
77 Kornhuber HH. Physiologie und Klinik des zentralvestibulären Systems (Blick- und Stützmotorik). In: Berendes J, Link R, Zöllner F. Hals-, Nasen- und Ohrenheilkunde. Bd III/3. Stuttgart: Thieme; 1966: 2197
78 Rambold H et al. Seesaw nystagmus associated with involuntary torsional head oscillations. Neurology 1998; 51: 831-837
79 Kömpf D, Piper HF. Eye movements and vestibulo-ocular reflex in the blind. J Neurol 1987; 234: 337-341
80 Watanabe R, Tachikawa H, Hayashi R et al. Steroid responsive chronic brainstem encephalitis featuring mental symptoms, abnormal eye movement and cerebellar ataxia. No To Shinkei 1997; 49: 650-653
81 Smith JH, Dhamija R, Moseley BD et al. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Arch Neurol 2011; 68: 1069-1072
82 Battaglia T, De Grandis E, Mirabelli-Badenier M et al. Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments. Eur J Paediatr Neurol 05.07.2011; [Epub ahead of print]
83 Dropcho EJ, Kline LB, Riser J. Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus. Neurology 1993; 43: 207-211
84 Fukuzawa T, Tashiro K, Hamada T et al. Multisystem degeneration: drugs and square wave jerks. Neurology 1986; 36: 1230-1233